Search clinical trials for: Relapsing multiple sclerosis
Total 14493 results
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
Terry L. WahlsCompleted
-
BayerCompleted
-
University of Colorado, DenverRocky Mountain MS Research Group, LLCCompletedMultiple SclerosisUnited States
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
American CryoStem CorporationTerminatedMultiple SclerosisCayman Islands
-
AbbVieCompletedMultiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisIreland
-
Bezmialem Vakif UniversityUnknownMultiple Sclerosis, Relapsing-Remitting
-
MidAmerica Neuroscience Research Foundation at...Biogen; Consultants in NeurologyCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
BayerCompletedMultiple SclerosisTurkey, Czechia, Hungary, Israel, Germany, France, Belgium, Greece, Netherlands, Egypt, Kazakhstan, Argentina, Portugal, Algeria, Saudi Arabia, Albania, Tunisia
-
Merck KGaA, Darmstadt, GermanyMerck Romania SRL, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedClinically Isolated Syndrome | Relapsing Multiple SclerosisGermany
-
CelgeneCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
Charite University, Berlin, GermanyBayerTerminatedRelapsing Remitting Multiple SclerosisGermany
-
Charite University, Berlin, GermanyGerman Research Foundation; Pfizer; German Federal Ministry of Education and...CompletedRelapsing Remitting Multiple Sclerosis
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
InteKrin Therapeutics, Inc.Completed
-
BiogenCompletedRelapsing Remitting Multiple SclerosisGermany
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Simnad, Virginia, M.D.NovartisUnknownMultiple SclerosisUnited States
-
University of MiamiNational Multiple Sclerosis Society; CerecinCompletedRelapsing Remitting MS | Secondary Progressive MS | Primary Progressive MSUnited States
-
NYU Langone HealthTerminatedMultiple SclerosisUnited States
-
University Hospital, BordeauxCompletedMultiple Sclerosis | Multiple Sclerosis, Acute RelapsingFrance
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompleted
-
Johns Hopkins UniversityCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BayerCompletedMultiple Sclerosis, Relapsing RemittingBelgium, Bosnia and Herzegovina, Italy, Austria, Croatia, Czechia, France, Greece, Hungary, Spain, Switzerland
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingSpain
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingPoland, Turkey, United States, Latvia, Lebanon, Germany, Belgium, Bulgaria, Czechia, Kuwait
-
Transparency Life SciencesUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
Nantes University HospitalCompletedRelapsing-remitting Multiple SclerosisFrance
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
NovartisCompletedMultiple SclerosisSwitzerland, Germany, Spain, Portugal, Canada, Denmark, Finland, France, Italy, Poland, United Kingdom
-
University of North Carolina, Chapel HillGenzyme, a Sanofi CompanyTerminatedRELAPSING REMITTING MULTIPLE SCLEROSISUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Relapsing-RemittingSweden, Germany
-
Imcyse SATerminatedMultiple Sclerosis, Relapsing-RemittingBelgium
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Merck KGaA, Darmstadt, GermanyCompleted
-
National Institute of Neurological Disorders and...CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States